Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Retina macular degeneration

Ferrara N, Damico L, Shams N, et al (2006) Developmemt of Ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26 859-870... [Pg.1272]

Dillon, J., L. Zheng et al. (2004). Transmission of light to the aging human retina possible implications for age related macular degeneration. Exp. Eye Res. 79(6) 753-759. [Pg.277]

The retina does not contain high concentrations of hydrocarbon carotenoids but Mares-Perlman et al. (1995) have shown a correlation between age-related macular degeneration and low levels of serum LYC and this apparent contradiction is discussed in Section 14.5. [Pg.300]

Chowers, I, Wong, R, Dentchev, T, Farkas, RH, Iacovelli, J, Gunatilaka, TL, Medeiros, NE, Presley, JB, Campochiaro, PA, Curcio, CA, Dunaief, JL, and Zack, DJ, 2006. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47, 2135-2140. [Pg.341]

Moshfeghi, DM and Blumenkranz, MS, 2007. Role of genetic factors and inflammation in age-related macular degeneration. Retina 27, 269-275. [Pg.348]

Age-related macular degeneration (AMD) is the main cause of irreversible blindness in the Western world and affects 20% of people older than 65 years (Krinsky and others 2003). The macula, or yellow spot, is part of the retina and is the area of maximum visual... [Pg.209]

Shaban, H., and Richter, C. A2E and blue light in the retina the paradigm of age-related macular degeneration. Biol. Chem. 383 537-545, 2002. [Pg.816]

Pathologic neovascularization of the retina is central to several debilitating ocular diseases including proliferative diabetic retinopathy (PDR), age-related macular degeneration (AMD), and retinopathy of prematurity (ROP). Diabetic retinopathy (primarily retinal NV) and the wet form of AMD (primarily choroidal NY) are the leading causes of blindness in developed countries. [Pg.104]

Eyetech Study Group, Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration, Retina, 22 143-152, 2002... [Pg.520]

Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes update. Retina 2005 25 119. [Pg.313]

Gonzales CR,VEGE Inhibition Smdy in Ocular Neovascularization (Vl.S.l.O.N.) Clinical Trial Group. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium an exploratory analysis. Retina 2005 25 815. [Pg.313]

Rich RM, Rosenfeld PJ, PuUafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for noevascular age related macular degeneration. Retina 2006 26 495. [Pg.314]

D Amico DJ, Goldberg MF, Hudson H, et al. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD) interim (month 6) analysis of clinical safety and efficacy. Anecortave Acetate Clinical Smdy Group. Retina 2003 23 14. [Pg.314]

See other pages where Retina macular degeneration is mentioned: [Pg.1256]    [Pg.75]    [Pg.88]    [Pg.206]    [Pg.559]    [Pg.163]    [Pg.815]    [Pg.104]    [Pg.322]    [Pg.121]    [Pg.29]    [Pg.1902]    [Pg.408]    [Pg.383]    [Pg.285]    [Pg.294]    [Pg.297]    [Pg.299]    [Pg.486]    [Pg.241]    [Pg.93]    [Pg.93]    [Pg.95]    [Pg.105]    [Pg.217]    [Pg.1256]    [Pg.123]    [Pg.72]    [Pg.34]    [Pg.51]    [Pg.313]    [Pg.2441]    [Pg.126]   
See also in sourсe #XX -- [ Pg.142 ]



SEARCH



Macular

Macular degeneration

Retina

© 2024 chempedia.info